Actions of N-Arachidonyl-Glycine in a Rat Inflammatory Pain Model
Open Access
- 1 January 2007
- journal article
- Published by SAGE Publications in Molecular Pain
- Vol. 3, 24
- https://doi.org/10.1186/1744-8069-3-24
Abstract
Background: While cannabinoid receptor agonists have analgesic activity in inflammatory pain states they produce a range of side effects. Recently, it has been demonstrated that the arachidonic acid-amino acid conjugate, N-arachidonyl-glycine (NA-glycine) is effective in acute pain models. Results: In the present study we examined the effect of NA-glycine in a rat model of inflammatory pain. Intrathecal administration of NA-glycine (70 – 700 nmol) and the pan-cannabinoid receptor agonist HU-210 (10 nmol) reduced the mechanical allodynia and thermal hyperalgesia induced by intraplantar injection of Freund's complete adjuvant (FCA). The actions of HU-210, but not NA-glycine were reduced by the cannabinoid CB1 receptor antagonist AM251. The cannabinoid CB2 receptor antagonist SR144528 also had no effect on the actions of NA-glycine. In contrast, N-arachidonyl-GABA (NA-GABA, 700 nmol) and N-arachidonyl-alanine (NA-alanine, 700 nmol) had no effect on allodynia and hyperalgesia. HU-210, but not NA-glycine produced a reduction in rotarod latency. Conclusion: These findings suggest that NA-glycine may provide a novel non-cannabinoid receptor mediated approach to alleviate inflammatory pain.Keywords
This publication has 33 references indexed in Scilit:
- Actions of N-arachidonyl-glycine in a rat neuropathic pain modelNeuropharmacology, 2008
- Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain modelsEuropean Journal of Neuroscience, 2003
- Selective activation of cannabinoid CB2 receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammationNeuroscience, 2003
- A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle painPain, 2003
- Regulation of anandamide tissue levels by N-arachidonylglycineBiochemical Pharmacology, 2002
- Selective oxygenation of N-arachidonylglycine by cyclooxygenase-2Biochemical and Biophysical Research Communications, 2002
- CB1 and CB2 cannabinoid receptors are implicated in inflammatory painPain, 2002
- Identification of a New Class of Molecules, the Arachidonyl Amino Acids, and Characterization of One Member That Inhibits PainJournal of Biological Chemistry, 2001
- CB2 cannabinoid receptor-mediated peripheral antinociceptionPublished by Wolters Kluwer Health ,2001
- HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptorProceedings of the National Academy of Sciences, 1999